Holen Sie sich die Stockscreener-App
10.82
0.69%
-0.0751
Schlusskurs vom Vortag:
$10.90
Offen:
$10.8343
24-Stunden-Volumen:
1,790
Relative Volume:
0.00
Marktkapitalisierung:
$6.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.42M
KGV:
-5.8831
EPS:
-1.84
Netto-Cashflow:
$-13.41M
1W Leistung:
-11.20%
1M Leistung:
+3,908%
6M Leistung:
+1,039%
1J Leistung:
+396.56%
1-Tages-Spanne:
$10.60
$10.83
1-Wochen-Bereich:
$10.60
$12.50
52-Wochen-Spanne:
$0.2701
$13.40
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Firmenname
Indaptus Therapeutics Inc
Sektor
Branche
Telefon
(646) 427-2727
Adresse
3 COLUMBUS CIRCLE, NEW YORK
Vergleichen Sie INDP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
10.82 | 6.98M | 0 | -15.42M | -13.41M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten
Is Indaptus Therapeutics Inc. a good long term investmentRapid market gains - jammulinksnews.com
Indaptus Therapeutics Inc. Stock Analysis and ForecastConsistent triple-digit returns - jammulinksnews.com
What analysts say about Indaptus Therapeutics Inc. stockUnstoppable profit momentum - jammulinksnews.com
What drives Indaptus Therapeutics Inc. stock priceBreakthrough investment results - Autocar Professional
Is Indaptus Therapeutics Inc. stock a good hedge against inflationFree Access to Community - Newser
How high can Indaptus Therapeutics Inc. stock price go in 2025Free Access to Community with 300% Return - Newser
what makes indaptus therapeutics inc. stock price move sharplyFree Step-by-Step Investment Guide - Newser
Indaptus Therapeutics regains compliance with Nasdaq minimum bid price rule - Investing.com Nigeria
Indaptus Regains Nasdaq Compliance with Bid Price - TipRanks
Indaptus Therapeutics (NASDAQ:INDP) Shares Down 3.1% – Should You Sell? - Defense World
What makes Indaptus Therapeutics Inc. stock price move sharplyFree Stock Market Query - Newser
How Indaptus Therapeutics Inc. stock performs during market volatilityFree Capital Allocation Plans - Newser
Why Indaptus Therapeutics Inc. stock attracts strong analyst attentionConsistent Growth Alert - Newser
Indaptus Therapeutics announces additional sale of $3.4M in private placement - TipRanks
Indaptus Therapeutics raises $5.7 million through convertible notes - Investing.com
Indaptus Therapeutics raises $5.7 million through convertible notes By Investing.com - Investing.com South Africa
Indaptus Therapeutics Raises $5.7 Million Through Convertible Promissory Notes and Warrants - Nasdaq
Indaptus Raises $5.7M in Private Placement: New Funding Accelerates Cancer Treatment Clinical Trials - Stock Titan
Indaptus Therapeutics Raises $5.7M for R&D Initiatives - TipRanks
Indaptus Therapeutics (INDP) Resumes Trading | INDP Stock News - GuruFocus
Indaptus Therapeutics (INDP) Trading Temporarily Suspended Ahead of Announcement | INDP Stock News - GuruFocus
Indaptus Therapeutics Announces Reverse Stock Split - citybiz
Why Did Indaptus Therapeutics Plunge 28.89%? - AInvest
3 Penny Stocks to Watch Now, 6/24/25 - TipRanks
Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results - Benzinga
Indaptus Therapeutics (INDP) Secures $2.3M Through Convertible N - GuruFocus
Indaptus Therapeutics raises $2.3 million through convertible notes By Investing.com - Investing.com South Africa
Indaptus Therapeutics Announces Sale Of $2.3 Million In Private Placement Of Convertible Notes And Warrants - MarketScreener
Indaptus Therapeutics Completes $2.3M Private Placement - TipRanks
Indaptus Therapeutics, Inc. Secures $2.3 Million Through Convertible Promissory Notes and Warrants in Funding Round - Nasdaq
Indaptus Therapeutics, Inc. Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants - The Manila Times
Bitcoin Depot Adds to Bitcoin Treasury Holdings Amid Continued Market Momentum - The Manila Times
Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):